// App-Quantinova.ai

P616 : Ustekinumab for refractory paediatric Crohn’s disease: experience from two UK tertiary referral centres

Researchers

Presenter

  • R Rao

Principal Investigators

  • R Gadhok

  • L Whitley

  • N Burgess

  • P Amon

  • S Naik

  • J Lindsay

  • S McCartney

  • K Kok

Medical Centers

  • The Royal London Hospital, Gastroenterology, London, UK

  • University College London Hospital, Gastroenterology, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • C reactive protein

Drug/Treatment

  • Ustekinumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved